Skip to main content

DPM Metals Announces Discovery of High-Grade Porphyry Mineralization Adjacent to Chelopech Mine; Results include 713 Metres at 2.52 g/t AuEq (comprising of 1.31 g/t Au and 1.16% Cu)

TORONTO, June 03, 2026 (GLOBE NEWSWIRE) — DPM Metals Inc. (TSX: DPM, ASX: DPM) (ARBN: 689370894) (“DPM” or “the Company”) is pleased to announce a major new discovery of high-grade, gold-copper porphyry mineralization at the Brevene South Porphyry (“BSP”) target, located in the southeastern part of the Company’s Brevene exploration licence and contiguous with the Chelopech mine concession. Highlights include:Major new discovery of a high-grade gold-copper porphyry system: Initial results from drilling program at BSP demonstrate potential for scale and continuity with broad, continuous intervals of high-grade gold-copper porphyry mineralization. Selected intercepts include:EX_BRESPO_03: 713 metres grading 2.52 g/t AuEq, comprising of 1.31 g/t Au and 1.16% Cu from 1,172 metres downhole, including 398 metres grading 3.00 g/t AuEq,...

Continue reading

T1 Energy to Enter BESS and Data Center Infrastructure Markets with Acquisition of KORE Power

Acquisition Expected to be EBITDA Accretive and Expand T1’s Commercial Reach into Battery Energy Storage Systems Development AUSTIN, Texas and NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) — T1 Energy Inc. (NYSE: TE) (“T1,” “T1 Energy,” or the “Company”) announced this morning it has entered into a definitive agreement to acquire KORE Power, Inc., an established engineering-focused BESS (Battery Energy Storage Systems) and software solutions provider supporting industrial hyperscaler development. The purchase enterprise value consists of approximately $32 million of equity, cash, and assumption of debt at anticipated closing in Q2 2026. The transaction is expected to provide T1 with an entry point into the energy storage and AI data center infrastructure markets through an expanded potential customer base for solar and storage solutions....

Continue reading

MannKind Enters Data-Rich Development Period with Completion of Randomization in Phase 1b INFLO-1 Study and Enrollment of First Patient in Phase 2 INFLO-2 Trial for Nintedanib DPI in Patients with IPF

Phase 1b INFLO-1 study data readout anticipated in Q3 2026DANBURY, Conn. and WESTLAKE VILLAGE, Calif., June 03, 2026 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD), a biopharmaceutical company focused on developing innovative, patient-centric therapies for chronic diseases, today announced key clinical execution milestones in the development of nintedanib DPI for idiopathic pulmonary fibrosis (IPF), including the completion of patient randomization in the U.S. Phase 1b INFLO-1 clinical trial and enrollment of the first patient in the global Phase 2 INFLO-2 study. These milestones mark the advancement of the nintedanib DPI program and support its progression into mid-stage clinical evaluation. Positioning for Continued Clinical Development in IPF MannKind expects to report data from the INFLO-1 study in the third quarter...

Continue reading

OwlTing Group (NASDAQ: OWLS) Secures Ohio Money Transmitter License, Extending U.S. Coverage to 42 States

The license extends OwlPay’s regulated settlement network into one of America’s largest industrial economies, anchored by a $55 billion aerospace and defense sector, and toward the payment rails the Company is building for agentic commerceARLINGTON, Va., June 03, 2026 (GLOBE NEWSWIRE) — OwlTing Group (NASDAQ: OWLS) (“OwlTing” or the “Company”), the operating brand of OBOOK Holdings Inc., a global fintech company, today announced that it has obtained a Money Transmitter License from the State of Ohio. The license brings OwlTing’s coverage to 42 U.S. states1 and extends the reach of OwlPay, the Company’s cross-border payment and settlement infrastructure, into one of the most industrially significant economies in the United States.2 Ohio is the seventh-largest state economy in the United States, with a GDP...

Continue reading

Mineralys Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock

RADNOR, Pa., June 03, 2026 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD), obstructive sleep apnea (OSA) and other diseases driven by dysregulated aldosterone, announced today the pricing of an underwritten offering of 5,660,378 shares of its common stock at a price of $26.50 per share. The aggregate gross proceeds to Mineralys from the offering, before deducting underwriting discounts and commissions and other estimated offering expenses, are expected to be approximately $150.0 million. All of the securities to be sold in the offering are to be sold by Mineralys. The offering is expected to close on or about June 4, 2026, subject to the satisfaction of customary closing...

Continue reading

GEN Restaurant Group Appoints Luke A. Hewko as Chief Financial Officer to Accelerate CPG and Multi-Channel Growth

Planned CFO succession brings a CPA and operator who built a direct-to-consumer business from the ground up and led a fintech platform through its sale to a Nasdaq-listed buyer, positioning GEN’s finance organization for expansion across CPG, retail, and online CERRITOS, Calif., June 03, 2026 (GLOBE NEWSWIRE) — GEN Restaurant Group, Inc. (“GEN” or the “Company”) (Nasdaq: GENK), owner and operator of GEN Korean BBQ, today announced the appointment of Luke A. Hewko, CPA, as Chief Financial Officer, principal financial officer, and principal accounting officer, effective June 1, 2026. Mr. Hewko succeeds Thomas V. Croal, who is retiring following a planned CFO succession process. “This was a planned leadership transition, and we are grateful to Tom for his service, leadership, and partnership,” said David Kim, Chairman and Chief Executive...

Continue reading

Form 8.3 – [ANIMALCARE GROUP PLC – 02 06 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ANIMALCARE GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position...

Continue reading

Heimstaden Bostad AB (publ) Issues SEK 650 Million Green Floating Rate Notes

Heimstaden Bostad AB (publ) successfully priced SEK 650 million green senior unsecured floating rate notes. The notes have a maturity of 3.5 years with a coupon of 3 months STIBOR plus 1.00 percent. The proceeds will be used in accordance with Heimstaden Bostad’s Green Financing Framework. The Green Financing Framework outlines the criteria for Heimstaden Bostad to issue green bonds. The framework has been reviewed by Sustainable Fitch, which has provided an “Excellent” Second-Party Opinion. An application will be made for the notes to be listed on Euronext Dublin. The final terms, once published, will be made available on both Euronext Dublin and heimstadenbostad.com. Danske Bank and Swedbank acted as joint bookrunners.    ContactFrederik Stentoft Berling, Media Relations,  +45 21 30 94 89, media@heimstaden.com Cody Nelson, Investor Relations, +47...

Continue reading

Zhihu Inc. Reports Unaudited First Quarter 2026 Financial Results

BEIJING, China, June 03, 2026 (GLOBE NEWSWIRE) — Zhihu Inc. (“Zhihu” or the “Company”) (NYSE: ZH; HKEX: 2390), a leading online content community in China, today announced its unaudited financial results for the quarter ended March 31, 2026. First Quarter 2026 HighlightsTotal revenues were RMB651.6 million (US$94.5 million), compared with RMB729.7 million in the same period of 2025. Gross margin was 59.6%, compared with 61.8% in the same period of 2025. Net loss was RMB8.5 million (US$1.2 million), narrowing by 15.6% from the same period of 2025. Adjusted net income (non-GAAP)[1] was RMB17.2 million (US$2.5 million), representing an increase of 147.2% from the same period of 2025. Average monthly subscribing members[2] were 13.1 million in the first quarter of 2026.“The first quarter of 2026 marked a solid start to the year,...

Continue reading

Form 8.3 – [ADVANCED MEDICAL SOLUTIONS GROUP PLC – 02 06 2026] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree ADVANCED MEDICAL SOLUTIONS GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.